Why the study?
Does aggressive treatment of systolic hypertension reduce cardiovascular events in aging patients?
Population
People over the age of 65 with hypertension, particularly systolic hypertension
Design
Review
Authors
Loading...
May support targeting SBP <140 mm Hg in elderly; leaves open dedicated RCTs for frail subgroups.
Does aggressive treatment of systolic hypertension reduce cardiovascular events in aging patients?
This review highlights the shift towards more aggressive management of systolic hypertension in the elderly to prevent cardiovascular events, in line with JNC VI and WHO-ISH guidelines.
Michael A. Weber (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: